IRIS
BATTAGLIA, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.297
EU - Europa 6.212
AS - Asia 2.199
SA - Sud America 43
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
AF - Africa 4
Totale 24.773
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.255
IT - Italia 2.671
CN - Cina 1.393
SE - Svezia 942
UA - Ucraina 708
DE - Germania 659
SG - Singapore 599
FI - Finlandia 418
GB - Regno Unito 272
FR - Francia 243
BE - Belgio 88
VN - Vietnam 73
IE - Irlanda 67
IN - India 66
CA - Canada 36
RU - Federazione Russa 32
CH - Svizzera 28
IR - Iran 22
BR - Brasile 17
KR - Corea 11
NL - Olanda 10
RO - Romania 10
AR - Argentina 9
CZ - Repubblica Ceca 9
AU - Australia 8
EU - Europa 8
LT - Lituania 8
ES - Italia 7
JP - Giappone 7
PT - Portogallo 7
CO - Colombia 6
PL - Polonia 5
TR - Turchia 5
VE - Venezuela 5
BD - Bangladesh 4
HR - Croazia 4
LU - Lussemburgo 4
MX - Messico 4
BG - Bulgaria 3
CL - Cile 3
DK - Danimarca 3
EG - Egitto 3
GR - Grecia 3
HK - Hong Kong 3
KZ - Kazakistan 3
TH - Thailandia 3
EE - Estonia 2
HU - Ungheria 2
IL - Israele 2
RS - Serbia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
BO - Bolivia 1
BT - Bhutan 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
SA - Arabia Saudita 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 24.773
Salva come PNG Salva come JPEG
Città #
Fairfield 2.034
Chandler 1.721
Jacksonville 1.615
Woodbridge 1.443
Ashburn 1.053
Houston 868
Seattle 849
Cambridge 769
Wilmington 707
Nyköping 663
Ann Arbor 638
Singapore 435
Lawrence 414
Roxbury 414
Nanjing 389
New York 290
Des Moines 275
Beijing 273
Bari 235
Boardman 179
Princeton 176
Rome 142
Milan 122
Shenyang 106
Nanchang 101
Inglewood 96
Hebei 95
San Diego 92
Brussels 84
Dearborn 74
Santa Clara 74
Dong Ket 73
Jiaxing 72
Brooklyn 66
Dublin 63
London 63
Tianjin 61
Changsha 57
Redwood City 56
Paris 49
Naples 48
Helsinki 46
Los Angeles 45
Munich 43
Florence 39
Pune 39
Bologna 33
Palermo 32
Turin 28
Falls Church 26
Guangzhou 26
Toronto 25
San Mateo 22
Augusta 21
Washington 21
Leawood 20
Hefei 17
Frankfurt am Main 15
Monmouth Junction 15
Torino 15
Auburn Hills 14
Norwalk 14
Bitonto 12
Brescia 12
Modugno 12
Verona 12
Mola Di Bari 11
Jinan 10
Kunming 10
Napoli 10
Ningbo 10
Shanghai 10
Ardabil 9
Chicago 9
Dallas 9
Lodi 9
New Bedfont 9
Tappahannock 9
Taranto 9
Trento 9
Catania 8
Mumbai 8
Wuhan 8
Hounslow 7
Ottawa 7
Perugia 7
Rimini 7
Trani 7
Zhengzhou 7
Altamura 6
Como 6
Ferentino 6
Hangzhou 6
Kilburn 6
Mcallen 6
Monopoli 6
Padova 6
Prescot 6
Salerno 6
Taizhou 6
Totale 17.903
Salva come PNG Salva come JPEG
Nome #
L’INFILTRAZIONE PERINEURALE E LA POSITIVITA’ DEI MARGINI CHIRURGICI NELLA PROGNOSI DEI PAZIENTI CON CARCINOMA PROSTATICO SOTTOPOSTI A PROSTATECTOMIA RADICALE. 1.508
ACCESSO LOMBOTOMICO VS ACCESSO TRANSPERITONEALE NELLA CHIRURGIA DEL CARCINOMA RENALE. RISULTATI PRELIMINARI DI UNO STUDIO RANDOMIZZATO. 584
LA FISTOLA CAVERNO-SPONGIOSA SECONDO WINTER NEL TRATTAMENTO DEL PRIAPISMO IDIOPATICO. 166
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 162
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer. 152
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 140
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 136
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 136
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function 133
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 133
LE ANASTOMOSI URETERO-INTESTINALI: CONDOTTO ILEALE CON URETERO - ILEOANASTOMOSI SECONDO WALLACE. 132
Isolation and characterization of cancer stem cells in renal cell carcinoma. 130
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 128
Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function 125
Capillary hemangioma of the scrotum mimicking an epididymal tumor: case report. 123
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 123
ANGIOMIOLIPOMA CALCIFICO DEL RENE. 120
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 120
null 119
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 116
Bilateral tumors of the testis in 21-alpha hydroxylase deficiency without adrenal hyperplasia 115
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation. 115
Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma 114
Complement-dependent NADPH oxidase enzyme activation in renal ischemia/reperfusion injury. 113
Allograft nephrectomy: Intracapsular vs extracapsular tecnique 110
Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature 109
Androgen deprivation therapy affects BCL-2 expression in human prostate cancer 109
UROCITOLOGIA E COLPOCITOLOGIA IN CLIMATERIO E NELLA SENILITA' 108
Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients 108
Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients 108
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 106
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury 106
T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function 105
Lethal somatostatin analog-induced acute necrotizing pancreatitis in a patient with hormone-refractory prostate cancer 104
Spontaneous rupture of an ileal neobladder 6 years after construction 103
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 103
Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. 102
Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trial 102
Repair of vaginal prolapse following penoscrotal flap vaginoplasty in a male-to-female transsexual 101
VHL gene alterations in Italian patients with isolated renal cell carcinomas 101
Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study 101
Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine 100
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 100
Incidental prostatic cancer: repeat TURP or biopsy? 100
Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients 99
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 99
BCG septicemia after radical cystectomy: a rare postoperative complication following BCG therapy 98
GOSERELIN ACETATE WITH OR WITHOUT FLUTAMIDE IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PROSTATE-CANCER 97
Experience of percutaneous access under ultrasound guidance in renal transplant patients with allograft lithiasis 97
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 96
Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma. 96
Penile prosthesis: what should we do about complications? 95
Advanced age is not an exclusion criterion for kidney transplantation. 95
Kidney transplants from infected donors: Our experience 93
Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study 92
Adjuvant hormone therapy after radical prostatectomy: Indications and results 91
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer 91
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage 90
Penile prosthesis implant: when, what and how 90
Complement activation during ischemia/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary Lumen Reduction Through pERK Signaling 90
Interleukin-27 is a potential marker for the onset of post-transplant malignancies 89
Allograft nephrectomy: what is the best surgical technique? 89
null 89
Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer. Anticancer Res. 2009 Oct;29(10):4201-4. PubMed PMID: 19846973 88
True mycotic arteritis by Candida albicans in 2 kidney transplant recipients from the same donor 88
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 87
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 87
Medical and surgical complications after kidney transplantation from "suboptimal donors": One centre's experience 87
Prospective randomized trial comparing high lumbotomic with laparotomic access in renal cell carcinoma surgery 87
Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report 87
Endothelial-to-Mesenchymal Transition (EndMT) in Swine Renal Ischemia Reperfusion (I/R) Injury Is Mediated by Complement and AKT Pathway 86
Predictive value of resistive index in graft survival after kidney transplant. 86
null 86
null 86
Middle and long-term outcomes of dual kidney transplant: a multicenter experience 86
ATTEMPT TO CORRECT IMMUNE DEFICITS IN PATIENTS WITH CHRONIC URINARY-TRACT INFECTION BY ADMINISTRATION OF A THYMIC EXTRACT 86
Current insights in renal cell cancer pathology 85
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 85
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 84
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 84
Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients 83
Androgen deprivation therapy regulation of beta 1C integrin expression in prostate cancer 83
Single-step surgical tretment of adrenal pheochromocytoma and medullary thyroid carcinoma in Sipple's Syndrome 83
ORAL PROPHYLAXIS WITH FOSFOMYCIN TROMETAMOL IN TRANSURETHRAL PROSTATECTOMY AND UROLOGICAL MANEUVERS - LITERATURE-REVIEW AND PERSONAL-EXPERIENCE 82
Adherence to the EAU guidelines on Penile Cancer Treatment: European, multicentre, retrospective study 82
Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years 82
Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin 82
Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles 82
A challenging surgical approach to locally advanced primary urethral carcinoma: A case report and literature review 81
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 81
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 81
Patient and partner satisfaction after AMS inflatable penile prosthesis implant 80
Double J stent with antireflux device in the prevention of short-term urological complications after cadaveric kidney transplantation: single-center prospective randomized study 79
Emerging urinary markers of renal injury in obstructive nephropathy. 77
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 77
Experience with cyclosporine: approaching the therapeutic window for C2 levels in maintenance kidney transplant recipients 77
Lymph node staging in early prostatic carcinoma with radioguided sentinel node biopsy 77
ATTUALI ORIENTAMENTI NEL TRATTAMENTO DEL LINFOCELE NEL TRAPIANTO RENALE. 75
PREDICTION OF RECURRENCE AND PROGRESSION IN PRIMARY SUPERFICIAL BLADDER-CANCER WITH DNA FLOW-CYTOMETRY 75
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: Updated results of a multicentric trial 75
Totale 11.864
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.199 0 0 0 0 740 382 699 515 740 343 577 203
2020/20214.292 391 288 316 269 525 158 390 285 408 524 411 327
2021/20222.909 171 425 52 128 159 181 124 169 168 212 464 656
2022/20234.676 708 418 248 462 538 618 94 508 773 55 139 115
2023/20241.713 201 317 110 112 124 451 57 99 23 51 33 135
2024/20251.287 130 136 608 282 131 0 0 0 0 0 0 0
Totale 25.386